Dyax

 

Advancing Novel Biotherapeutics Since 1995®

Spotlight

DX-2930 is a fully human monoclonal antibody inhibitor of active plasma kallikrein. It is an investigational drug candidate in development for the prevention of hereditary angioedema (HAE) attacks.